Half-year report H1 2025

Revenio Group Corporation published it's Half-year report January-June 2025 on Thursday, August 7, 2025. See the materials below.

Welcome to Revenio's investor website

Revenio is a leading company in the global market for ophthalmological devices and software solutions. Revenio’s ophthalmic diagnostic solutions include intraocular pressure (IOP) measurement devices (tonometers), fundus imaging devices, and perimeters as well as clinical software under the iCare brand. iCare is a trusted partner in ophthalmic diagnostics, offering physicians fast, easy-to-use, and reliable tools for the diagnosis of glaucoma, diabetic retinopathy, and macular degeneration (AMD). iCare Solutions provide digital clinical tools that drive greater efficiency and enhance quality in eye care.



Outlook and guidance

See our guidance

Upcoming events

Latest video

Investor contacts

CFO Robin Pulkkinen robin.pulkkinen(at)revenio.fi